PDE5 inhibitor medications

Recent studies show around 50% of people stop using PDE5 inhibitor medications1

1. Carvalheira et al., “Dropout in the Treatment of erectile dysfunction (ED) with PDE5: A Study on Predictors and a Qualitative Analysis of Reasons for Discontinuation,” Journal of Sexual Medicine, May 2012

Benefits of SPONTAN® (vardenafil HCL nasal spray)

  • Non-invasive
  • Bypasses the Liver and first pass metabolism
  • Large highly vascular surface of the inner nostrils improves bioavailability
  • Provides therapeutic effect at lower dose
  • Provides faster onset of action
  • Reduces the risk of systemic exposure and side effects
  • More convenient for certain patient groups such as those with dysphagia